Skip to main content

Tegretol

NDC 0078-0511 · Novartis Pharmaceuticals Corporation

Generic namecarbamazepine
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)CARBAMAZEPINE
Strength200 mg/1
Pharmacologic classCytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
Marketing categoryNDA

Packages

0078-0511-05 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0078-0511-05)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0508 — carbamazepine, 0078-0509 — carbamazepine, 0078-0510 — carbamazepine, 0078-0512 — carbamazepine, 0615-8125 — Carbamazepine, 0615-8545 — Carbamazepine, 0832-6022 — Carbamazepine, 0832-6023 — Carbamazepine, 0832-6024 — Carbamazepine, 0904-3854 — CARBAMAZEPINE, 0904-6172 — CARBAMAZEPINE, 0904-6885 — Carbamazepine, 13668-268 — CARBAMAZEPINE, 13668-271 — CARBAMAZEPINE, 13668-284 — Carbamazepine, 13668-285 — Carbamazepine, 13668-286 — Carbamazepine, 16571-680 — CARBAMAZEPINE, 16571-681 — CARBAMAZEPINE, 16571-682 — CARBAMAZEPINE, +134 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T42.1X1 — Poisoning by iminostilbenes, accidental (unintentional), T42.1X2 — Poisoning by iminostilbenes, intentional self-harm, T42.1X3 — Poisoning by iminostilbenes, assault, T42.1X4 — Poisoning by iminostilbenes, undetermined, T42.1X5 — Adverse effect of iminostilbenes, T42.1X6 — Underdosing of iminostilbenes

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.